“Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models”, Rev Diabet Stud, pp. 1–21, Sep. 2025, doi: 10.1900/q356v768.